Selecta Biosciences (SELB) Misses Q3 EPS by 9c; Reports Cash and Cash Equivalents of $140.0M

Selecta Biosciences (NASDAQ: SELB) reported Q3 EPS of ($0.16), $0.09 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $24.4 million versus the consensus estimate of $12.19 million.

For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• United Community Banks (UCBI) Tops Q1 EPS by 2c
• Amphenol (APH) Reports Q1, Announces $2B Share Buyback